Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5050
+0.0156 (3.19%)
At close: Dec 31, 2025, 4:00 PM EST
0.5011
-0.0039 (-0.77%)
After-hours: Dec 31, 2025, 8:00 PM EST
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $52.83 million as of December 31, 2025. Its market cap has increased by 143.00% in one year.
Market Cap
52.83M
Enterprise Value
75.70M
1-Year Change
143.00%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $52.83M, an increase of 53.17%. That is a compound annual growth rate of 39.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |